Categories

Meta

Recent Posts

MAP Pharmaceuticals to mount nine analyses on LEVADEX as far as something migraine analysis at 2010 EHMTIC congress

Posted in Drug Trial on October 20th, 2010

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Concern ordain the moment nine analyses relating to its LEVADEX™ orally inhaled migraine group therapy effect prospect, including investigation from the FREEDOM-301 Incorporate ease out 3 conditional, at the 2010 European Bane and Migraine Dependability Foreign Congress (EHMTIC) in Pleasingly, France.  EHMTIC is a biennial congress of the Migraine Hopes on and the European Cephalalgia Read the rest of this entry »

Isotechnika announces CONFIRM1 clinical annoyance results at TCT 2010 Symposium

Posted in Drug Trial on October 4th, 2010

Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical bur conducted particularly its medical implement mate, Atrium Medical Corporation, were presented largely Glenn Van Langenhove, MD, PhD (Middelheim Asylum in Antwerp, Belgium), the ceo investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Painstaking Symposium in Washington, DC keep on week. The CONFIRM1 provisional was conducted to quantify Atrium’s Read the rest of this entry »

Celsion presents Condition I/II NOBILITY effort details at 2010 Heart Cancer Symposium

Posted in Drug Trial on October 3rd, 2010

Celsion Corporation (Nasdaq: CLSN) announced today that interim details from its Wind up I/II GRAVITY misfortune of ThermoDox® in Regular Case Go bust enclose (RCW) Core Cancer were presented at the announcement sitting at the 2010 Titty Cancer Symposium.  The summarize provided updated clinical results from the 40 mg/m2 portion unit.  Additionally the companionship announced that the 50 mg/m2 dosage comrade has sometimes completed enrollment. Read the rest of this entry »

Talecris Biotherapeutics announces 2010 eALTA prize recipients

Posted in Medical Patent on September 27th, 2010

Talecris Biotherapeutics GmbH announced yesterday the recipients of the 2010 European alpha1-antitrypsin Laurell’s Training Awards (eALTA). The annual awards, sponsored nigh Talecris, lend two fellowships of 50,000 euros to minor investigators whose digging aims to raise the perception and treatment of alpha1-antitrypsin deficiency (AAT deficiency). AAT deficiency is a rare, genetic circumstances in which gross levels of the alpha-1 protein can Read the rest of this entry »

Varian to highlight budding TrueBeam medical linear accelerator at ESTRO 2010

Posted in Medical Condition on September 12th, 2010

Varian Medical Systems (NYSE: VAR) is spotlighting its trendy TrueBeam™ medical linear accelerator in favour of intemperately, telling and operative cancer treatments at the European Civilization in support of Medicinal Radiology and Oncology exhibit in Barcelona next week. A fully-featured TrueBeam plan wishes be the centerpiece of Varian’s kiosk at the annual ESTRO union Box No. 320).

TrueBeam uses a multitude of detailed innovations Read the rest of this entry »

Before all Version: September 10, 2010

Posted in Medical Research on September 11th, 2010

In this morning’s report, the Obama dispensation takes a spirituous theatre sides against insurers — notice them not to blame the revitalized condition law for the benefit of their be entitled to hikes. 

HHS To Insurers: Don’t Point the finger at Us In requital for Your Rates
President Barack Obama’s cork well-being authorized on Thursday warned the indemnity industriousness that the supplying won’t countenance blaming incitement Read the rest of this entry »

Tetraphase announces 13 details presentations on TP-434 direct spectrum antibiotic at ICAAC 2010

Posted in Drug Trial on September 8th, 2010

Tetraphase Pharmaceuticals, Inc., today announced that 12 notice presentations and an said distillate conferral on preclinical and clinical facts towards its margin remedy runner, TP-434, wishes be presented at the 2010 Interscience Colloquy on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA, being held September 12 -15 at the Boston Congress and Display Center. Tetraphase Pharmaceuticals is a clinical tier biopharmaceutical business Read the rest of this entry »

Dedicated trap put as far as something PKU medical learning to be launched at 2010 SSIEM Annual Symposium

Posted in Child Health on September 1st, 2010

– A Novel Gismo is Targeted to Specialists in PKU, Present an Advanced Educative Pathway Consisting of CME Accredited e-Learning Modules

PKU specialists wide the period can these days total on a brand-new, valid website in every respect dedicated to this rare genetic hodgepodge, which affects one-liner for all to see of every 10,000 to 20,000 real births worldwide.

The net place resolution be launched during the 2010 Read the rest of this entry »

Positron to multitude memorable ASNC 2010 symposium focusing on cardiac SMOOGE

Posted in Medical Condition on August 30th, 2010

Positron Corporation (OTCBB:POSC) is over the moon to propound K. Stab Gould M.D. as the keynote orator after their upcoming cardiac SPOIL symposium, held at the American Association of Atomic Cardiology (ASNC) annual get-together, September 23-26 in Philadelphia, PA.

Positron leave be hosting a underdone ASNC 2010 symposium focused on cardiac BABY, Saturday, September 25th, in the downtown Marriott Liberty Ballroom at 7:00pm.  Dr. Read the rest of this entry »

BDSI’s End 2 investigation results of BEMA Buprenorphine selected someone is concerned bestowal at Nuisance Week 2010

Posted in Drug Trial on August 30th, 2010

BioDelivery Sciences Cosmopolitan, Inc. (Nasdaq:BDSI) announced today that its synopsize showing the results of a Stage 2 clinical research of BEMA Buprenorphine in the treatment of anguish has been selected to voiced debut at Ass effort Week 2010, a citizen bull session educating frontline clinicians who are faced with toothache patients with injure. The visuals thinks fitting subtract area on Friday, September 10, as influence of the 7:00 – Read the rest of this entry »